ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

February 13, 1976

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

MD Anderson Faculty Slam Leadership, Question Moon Shots, Bemoan Workload

March 29, 2013

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998